Vol 119, No 1 (Supplement) 2014
Supplement abstract

Glands of bile and pancreatic ducts as a niche of biliary stem cells and pancreatic committed progenitors

Published 2015-03-19

Keywords

  • Peribiliary glands,
  • stem cell,
  • multipotent

How to Cite

Carpino, G., Onori, P., Renzi, A., Cardinale, V., Reid, L., Alvaro, D., & Gaudio, E. (2015). Glands of bile and pancreatic ducts as a niche of biliary stem cells and pancreatic committed progenitors. Italian Journal of Anatomy and Embryology, 119(1), 38. Retrieved from https://oajournals.fupress.net/index.php/ijae/article/view/2391

Abstract

Peribiliary glands (PBGs) in bile duct walls (Carpino et al., 2012), and pancreatic duct glands (PDGs) associated with pancreatic ducts contain a continuous, ramifying network of cells in overlapping maturational lineages (Wang et al., 2013). Our aims have been to investigate the presence of stem/progenitor cells within glands associated with bile and pancreatic ducts. Our results showed that proximal (PBGs)-todistal (PDGs) maturational lineages start near the duodenum with cells expressing markers of pluripotency (NANOG, OCT4, and SOX2) and proliferation (PCNA), and early hepato-pancreatic commitment (SOX9, SOX17, PDX1, and LGR5), transitioning to PDG cells with no expression of pluripotency or self-replication markers, maintenance of pancreatic genes (PDX1), and expression of markers of pancreatic endocrine maturation (NGN3, MUC6, and insulin). Biliary tree-derived cells behaved as stem cells in culture under expansion conditions, proliferating for months as undifferentiated cells; on the other hand, pancreas-derived cells underwent only approximately 8-10 divisions, then partially differentiated towards an islet fate. Both could be driven for an islet fate (HDM-P), to form spheroids with ultrastructural, electrophysiological and functional characteristics of neo-islets, including glucose regulatability. Implantation of these neo-islets into epididymal fat pads of immunocompromised diabetic mice was able to alleviate hyperglycemia by the secretion of glucose-regulated human C-peptide.